Shahar Dotan
Impact in
- Immunology top 2%
- Immune Cell Function and Interaction
- Immune cells in cancer
- IL-33, ST2, and ILC Pathways
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 13
- Immune Response and Inflammation 6
- Immune Cell Function and Interaction 4
- Immune cells in cancer 4
- Immunotherapy and Immune Responses 4
-
- Angiogenesis and VEGF in Cancer 2
- Co-authors
- Ron N. Apte (14 shared papers)Elena Voronov (12 shared papers)Yaron Carmi (7 shared papers)Charles A. Dinarello (8 shared papers)Malka R. White (6 shared papers)Moshe Elkabets (8 shared papers)Yakov Krelin (5 shared papers)Peleg Rider (5 shared papers)
- Journals
- The Journal of Immunology (4 papers)PLoS ONE (2 papers)Scientific Reports (2 papers)Biochemical and Biophysical Research Communications (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Shahar Dotan
20 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 136
- Immunology 1.1k
- Oncology 460
- Cancer Research 227
- Molecular Biology 947
- Epidemiology 322
Countries citing papers authored by Shahar Dotan
This map shows the geographic impact of Shahar Dotan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shahar Dotan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shahar Dotan more than expected).
Fields of papers citing papers by Shahar Dotan
This network shows the impact of papers produced by Shahar Dotan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shahar Dotan. The network helps show where Shahar Dotan may publish in the future.
Co-authors
The 25 scholars most cited alongside Shahar Dotan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 489 | |
| 2 | 2010 | 279 | |
| 3 | 2011 | 247 | |
| 4 | 2007 | 230 | |
| 5 | 2013 | 199 | |
| 6 | 2009 | 173 | |
| 7 | 2006 | 171 | |
| 8 | 2013 | 167 | |
| 9 | 2019 | 107 | |
| 10 | 2011 | 90 | |
| 11 | 2011 | 81 | |
| 12 | 2010 | 53 | |
| 13 | 2019 | 34 | |
| 14 | 2009 | 27 | |
| 15 | 2016 | 24 | |
| 16 | 2013 | 20 | |
| 17 | 2009 | 17 | |
| 18 | 2009 | 12 | |
| 19 | 2013 | 4 | |
| 20 | 2023 | 2 |
About Shahar Dotan
Shahar Dotan is a scholar working on Immunology, Molecular Biology, Epidemiology, Oncology and Public Health, Environmental and Occupational Health, having authored 20 papers that have together received 2.4k indexed citations. Recurring topics across this work include Immune Response and Inflammation (6 papers), Immune Cell Function and Interaction (4 papers), Immune cells in cancer (4 papers), Immunotherapy and Immune Responses (4 papers), Pneumonia and Respiratory Infections (3 papers), Angiogenesis and VEGF in Cancer (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Trypanosoma species research and implications (1 paper). The work is most often cited by research in Immunology (1.1k citations), Oncology (460 citations), Cancer Research (227 citations), Molecular Biology (947 citations) and Epidemiology (322 citations). Shahar Dotan has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Ron N. Apte, Elena Voronov, Yaron Carmi, Charles A. Dinarello, Malka R. White, Moshe Elkabets, Yakov Krelin, Peleg Rider, Eli Reich and Mina Fogel. Their work appears in journals such as The Journal of Immunology, PLoS ONE, Scientific Reports, Biochemical and Biophysical Research Communications and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.